-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan Pharmaceutical
A leading domestic company in the chemical pharmaceutical raw materials segment, with over 20 years of industry experience
Driven by the innovative integration of chemical and biological synthesis technologies
Continuously strengthening core advantages in areas such as blood sugar reduction and cardiovascular diseases, expanding into emerging fields such as cosmetic raw materials, high-end pharmaceutical excipients, and functional food additives, building an industrial ecosystem of "raw materials + multi-field synergy"
Focusing on integrated raw materials and preparations, and integrated excipients and preparations
Core products have obtained certifications from multiple countries, including the US FDA, EU CEP, Japan PMDA, and Korea MFDS
Cooperation partners span more than 20 countries and regions globally
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline